29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Governor Cuomo signed the groundbreaking harassment legislation that we previously covered here on A...
Read More >
On January 13, 2020, the U.S. Department of Labor (DOL) released its highly anticipated Final Rule r...
Read More >
Commuting by bicycle has grown in popularity in the last 20 years, with the number of cyclists in th...
Read More >
Although a whistleblowing employee typically cannot release fraud claims against her employer brough...
Read More >
The achievement of legislative consensus in 2018 around a preferred approach to safeguarding U.S. te...
Read More >
As a follow up to Bilzin Sumberg's Land Development & Government Relation's December 2019 Update reg...
Read More >